These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 19922963
1. A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation. Steinhardt AP, Aranguren F, Tellechea ML, Gómez Rosso LA, Brites FD, Martínez-Larrad MT, Serrano-Ríos M, Frechtel GD, Taverna MJ. Metabolism; 2010 May; 59(5):711-7. PubMed ID: 19922963 [Abstract] [Full Text] [Related]
2. Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Cuda C, Badawi A, Karmali M, El-Sohemy A. Metabolism; 2011 Aug; 60(8):1131-5. PubMed ID: 21306745 [Abstract] [Full Text] [Related]
3. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G. Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474 [Abstract] [Full Text] [Related]
4. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Hsu LA, Ko YL, Wu S, Teng MS, Chou HH, Chang CJ, Chang PY. Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054 [Abstract] [Full Text] [Related]
5. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Blackburn P, Lemieux I, Alméras N, Bergeron J, Côté M, Tremblay A, Lamarche B, Després JP. Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769 [Abstract] [Full Text] [Related]
6. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome. Khan SH, Khan FA, Ijaz A, Sattar A, Dilawar M, Hashim R. J Ayub Med Coll Abbottabad; 2008 Aug; 20(3):17-22. PubMed ID: 19610507 [Abstract] [Full Text] [Related]
7. The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese. Lee IT, Lee WJ, Huang CN, H-H Sheu W. Metabolism; 2007 Dec; 56(12):1708-13. PubMed ID: 17998025 [Abstract] [Full Text] [Related]
8. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [Abstract] [Full Text] [Related]
9. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome. González-Sánchez JL, Zabena C, Martínez-Larrad MT, Martínez-Calatrava MJ, Pérez-Barba M, Serrano-Ríos M. Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276 [Abstract] [Full Text] [Related]
10. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, Sowa P, Adamczyk-Sowa M, Kukla M, Berdowska A, Rehfeld JF, Bielanski W, Brzozowski T. J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025 [Abstract] [Full Text] [Related]
11. Maternal waist circumference and the prediction of children's metabolic syndrome. Hirschler V, Roque MI, Calcagno ML, Gonzalez C, Aranda C. Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567 [Abstract] [Full Text] [Related]
12. The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin. Jang Y, Lee JH, Kim OY, Koh SJ, Chae JS, Woo JH, Cho H, Lee JE, Ordovas JM. Metabolism; 2006 Jan; 55(1):59-66. PubMed ID: 16324920 [Abstract] [Full Text] [Related]
13. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women. Milewicz A, Tworowska-Bardziñska U, Dunajska K, Jêdrzejuk D, Lwow F. Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844 [Abstract] [Full Text] [Related]
14. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults. Can AS, Ozbayrakçi S, Palaoğlu KE, Bersot TP. J Cardiometab Syndr; 2009 Nov; 4(1):26-32. PubMed ID: 19245513 [Abstract] [Full Text] [Related]
15. Measures of obesity and metabolic syndrome in Indian Americans in northern California. Misra KB, Endemann SW, Ayer M. Ethn Dis; 2006 Nov; 16(2):331-7. PubMed ID: 17682232 [Abstract] [Full Text] [Related]
16. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M, Nicholls MG. Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631 [Abstract] [Full Text] [Related]
17. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, Vidal O. Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453 [Abstract] [Full Text] [Related]
18. C-reactive protein is elevated in obese patients with the metabolic syndrome. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R. Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176 [Abstract] [Full Text] [Related]
19. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome. Rhee EJ, Oh KW, Lee WY, Kim SY, Oh ES, Baek KH, Kang MI, Kim SW. Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192 [Abstract] [Full Text] [Related]
20. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Solymoss BC, Bourassa MG, Lespérance J, Levesque S, Marcil M, Varga S, Campeau L. Coron Artery Dis; 2003 May; 14(3):207-12. PubMed ID: 12702923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]